Online Inquiry
Cat.#: ACPP-1243
| Despition | ELOVL4 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1820 | Rat CNTF Protein, His (AC1820) | 2 µg | inquiry |
| ACPP-1321 | NPY5R Blocking Peptide (AC1321) | 250 µg | inquiry |
| ACPP-1779 | Human HSD17B10 Protein (AC1779) | 5 µg | inquiry |
| ACPP-1739 | Human SYT3 Protein (AC1739) | 5 µg | inquiry |
| ACPP-1761 | Human VCAM1 Protein (AC1761) | 2 µg | inquiry |
| ACPP-1754 | Human VEGFC Protein, Sf9 (AC1754) | 2 µg | inquiry |
| ACPP-1581 | Rat FGF 9 Protein (AC1581) | 2 µg | inquiry |
| ACPP-1445 | Human RAB4A Protein (AC1445) | 2 µg | inquiry |
| ACPP-1050 | Recombinant Human LIF Protein (Fc Tag) (AC1050) | 50 µg | inquiry |
| ACPP-1294 | DCC Blocking Peptide (AC1294) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.